NUREXONE BIOLOGIC INC (NRX.CA) Stock Analyst Ratings
Canada - TSX-V:NRX - CA67059R1091 - Common Stock
1.01 CAD
0 (0%)
ChartMill assigns a Buy % Consensus number of 84% to NRX.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.12. This target is 208.52% above the current price.
NRX.CA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NRX.CA.
In the previous month the buy percentage consensus was at a similar level.
NRX.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.